Afzanna 20mg Tablet

Afzanna 20mg Tablet

Prescription requiredRx Required

Salt Composition: Afatinib

Expiry Date: 01/2028

Special offer

Buy at $100.00

$100.00

Inclusive of all taxes

28 tablets in Bottle

About The Product

Lung Cancer, monotherapy


Description

Afzanna 20mg tablet is a targeted anti-cancer medication which is highly recommended to lung cancer patients by healthcare professional. The medicine works by blocking epidermal growth factor receptor (EGFR) which is involved in the growth and multiplication of cancer cells in the body, thereby helping to slow or stop tumor progression.

Medication contains Afatinib as its active ingredient which is present in its salt composition which helps to slow down the process of formation of cancer cells in the body. Strict medical guidelines must be followed during the treatment to ensure safety and effectiveness of the treatment.

Indication

Non small cell lung cancer

Common side effects

  • Afzanna 20mg tablet cause side effects in some patients and these can vary from mild to moderate depending on individual response and overall health outcomes.
  • Discuss with doctor if the symptoms persist: ● Loss of appetite ● Abdominal pain ● Interstitial lung disease (ILD) ● Severe diarrhea or dehydration ● Liver problems ● Diarrhea ● Mouth sores ● Acne or skin rash ● Dry skin or itching ● Eye irritation or dryness ● Respiratory infections

Dosage and duration

  • Afzanna 20mg tablet is a prescription based medication, doctors suggest consuming the medicine on an empty stomach at the same time everyday with a whole glass of water.
  • Never skip or double the dose, if you miss a dose take the next one at the schedule time unless your advises otherwise.
  • Taking it in the wrong way may cause serious side effects and lead to complications.

Mechanism of the action

Lung cancer is caused by epidermal growth factor receptor (EGFR) which is a primary cause of cancer cell growth and multiplication of cancer cells in the body. Afzanna tablet work by binding and inhibiting the enzyme EGFR, thereby helping to stop the growth and multiplication of cancer cells.

Doctors prescribed this medication to patients whose cancer cell is driven by EGFR mutation, based on their medical condition and treatment plan.

Safety advice

Alcohol
The person who are addictive to alcohol should stop consuming it immediately while taking Afzanna 20mg tablet, as it can interrupt the treatment journey.
Driving
It is unknown whether Afzanna tablet affect driving but if you experience any of the symptoms must consult the doctor Immedietly.
Pregnancy
Pregnant women should avoid using Afzanna 20mg tablet because its safety during pregnancy has not been established, and it may cause serious harm to the developing fetus.
Breast Feeding
Afzanna 20mg tablet should not be used by breastfeeding women, as the medicine is pass into breast milk and may harm the nursing baby.
Kidney
Kidney patients can use Afzanna 20mg tablet because it does not harm the patient but it is better to consult the doctor before using the medication.
Liver
Afzanna 20mg does not harm the liver patient but liver function should be monitored by a doctor during treatment journey to ensure safety.

FAQs

Afzanna 20mg tablet treats non small cell lung cancer (NSCLC) by blocking the growth of abnormal protein causing cancer cell in the body.

Reference

• Wecker, H., & Waller, C. F.

(2018). Afatinib.

Small Molecules in Oncology, 199-215. • Dungo, R. T., & Keating, G.

M. (2013).

Afatinib: first global approval. Drugs, 73(13), 1503-1515. • Wind, S., Schnell, D., Ebner, T., Freiwald, M., & Stopfer, P.

(2017). Clinical pharmacokinetics and pharmacodynamics of afatinib.

Clinical pharmacokinetics, 56(3), 235-250. • Nelson, V., Ziehr, J., Agulnik, M., & Johnson, M. (2013).

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC. OncoTargets and therapy, 135-143. • Keating, G.

M. (2014).

Afatinib: a review of its use in the treatment of advanced non-small cell lung cancer. Drugs, 74(2), 207-221.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026